Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Pharma
jeevan patwa
jeevanpatwa
#Suven – Journey of my first 50 bagger…I bought #Suven first in Apr 2013 around Rs 20…today after almost 7.5 years, its Rs 1000 (Suven pharma 920 adjusted for bonus
Read more
Cory Doctorow #BLM
doctorow
With its US body count around 200k, the opioid epidemic may seem like small potatoes next to the slaughter of the bungled covid response, but it's a still-suppurating wound on
Read more
Laurie Tomlinson
Roxytonin
There are some threads circulating to be RT by NHS staff about being keen to have the SARS-CoV-2 vaccine, to provide reassurance. I should RT it but I have complicated
Read more
The Pathfinder
path1finder
Thread about $XENE Xenon Pharmceuticals‘ main asset XEN1101: XEN1101 is a – presumably – much improved version of an older approved drug: ezogabine (= retigabine; trade names EU/USA Trobalt/Potiga). This
Read more
The Hans Scholl Liberation Front
uTobian
Ruh roh: every article in the NY Times Sunday Review today is about how normalcy will never return. They are right... but their reporters are unaware of the actual underlying
Read more
Heidi Chow
hidschow
This is great news. I only wish other countries could also have this headline but they don't becausehttps://www.bbc.co.uk/news/health-55145696 Pfizer has sold most of its vaccine stocks to rich countries, leaving
Read more
Stephen Fasenfeld 😀
fasenfeld
1. “Why Big Pharma Companies No Longer Need Sales Reps For Selling Their Products” A Personal Story & 1/25 2. My first job out of College after I left
Read more
+
Chaya48173118
@AmbatiRambabu About divis pharma while they are in opposotion https://twitter.com/Chaya48173118/status/1347123103957061641?s=20 @ysjagan about pollution caused by DIVIS pharma company @ysjagan Royya pillalanu chempeyyadaniki permission icc
Read more
Finance ASMR
financeasmr
Antares Pharma $ATRS is one expensive stockBut being in the healthcare sector and a small-cap, how great is this stock and what opportunity does it provide for investors?Let’s find out
Read more
Amanda Fa La La Blah
HollandAlways
If we looked at agencies like how most recruiters look at books:-You have a lot of stunt work, so, you're stunt agency.-Most of your work are banners, so you only
Read more
Dr. Thrasher, jouRNAlist
thrasherxy
1/ A thread of things I will read & re-read this weekend, thinking thru the production of the viral underclass w newly published research & who we should reading to
Read more
Shrey Srivastava
BlogShrey
#DDDD $DDDD $LBPS $LOAChttp://thepharmaletter.com/article/platforms-versus-products-in-the-life-sciences-sector'One common such weakness is often the failure of management teams to differentiate between the value of technology-derived m
Read more
Sara Nayeem
SaraNayeem
Suggestions for biopharma co’s on positioning BD efforts to investors: 1) Don’t suggest that you’ll partner out your lead program. Generally inv’s will appreciate licensing deals for the revenue they
Read more
Danyaal Raza
DanyaalRaza
An important conversation, but tough reality below.Bill Gates & his foundation have funded incredible, life changing Global Health work. However, Gates' commitment to patent rights & implications for COVID-19 vaccines
Read more
Michael Stumo
michael_stumo
1/ This EO for Buy American drugs was long awaited. Big Pharma fought it and lost. At its core, the EO is designed to provide a base market for US-based
Read more
K. Whitney-Daniels
KWhitneyDaniels
I'm seeing a lot about Biden freezing the Trump EO on insulin so it's thread time:This seems counterintuitive but this freeze is actually a GOOD thing for patients. The original
Read more
‹
1
2
3
4
5
6
7
8
...
54
55
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree